India Drug Innovators Threaten To Take Clinical Trials Elsewhere
This article was originally published in PharmAsia News
Executive Summary
Biocon, Lupin and other India drug makers threatened to move clinical trials for their drugs out of the country in lieu of the back-and-forth confusion between the Supreme Court and drug regulators over safety issues.